All material subject to strictly enforced copyright laws. © 2021 Euromoney Institutional Investor PLC group
Syndicated LoansLeveraged Loans

Grünenthal considers funding options after reports of scrapped leveraged debt sale

pills adobe stock 575x375 pharmaceuticals

Grünenthal, the German pain relief medicine maker, has extended the maturities on €535m of term loan facilities, telling GlobalCapital it is open to various financing options, after a press report saying investors had shunned a new euro leveraged loan.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree